Early Recurrence Patterns After Neoadjuvant Chemoradiotherapy and Chemoimmunotherapy in Oesophageal Squamous Cell Carcinoma: A Multicentre Study
European Journal of Cardio-Thoracic Surgery · 02.11.2026 · 68 (11-12)
DOI: 10.1093/ejcts/ezag219 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 08.09.2026. Verfasst von Cien Sun und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Taizhou Hospital of Zhejiang Province affiliated with Wenzhou Medical University, Linhai 317000, China. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Esophageal Neoplasms, Neoplasm Recurrence, Local, Esophageal Squamous Cell Carcinoma. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical and Health Science and Technology Project of Zhejiang Province, Scientific Research Foundation of Taizhou Enze Medical Center.
Abstract (Originalsprache)
Objectives
The goal of this study was to compare early recurrence patterns and survival outcomes between neoadjuvant chemoimmunotherapy (NCIT) and neoadjuvant chemoradiotherapy (NCRT) in patients with locally advanced oesophageal squamous cell carcinoma.
Methods
This retrospective cohort study included 1428 patients with stage IIB-IVA esophageal squamous cell carcinoma who underwent NCIT or NCRT followed by a radical surgical procedure. Outcomes included overall survival (OS), recurrence-free survival, loco-regional recurrence, distant metastasis, and post-recurrence survival. Propensity score matching (1:1 ratio, 0.1 caliper; balance threshold: standardized mean difference <0.10) and multivariable Cox regression were utilized.
Results
After propensity score matching (532 patients per group), the NCIT group exhibited better 3-year OS (72.2% vs 60.9%; hazard ratio [HR], 0.69; 95% confidence interval [CI], 0.56-0.85; P < .001) and recurrence-free survival (67.8% vs 59.3%; HR, 0.70; 95% CI, 0.57-0.86; P < .001) than the NCRT group. The NCIT group also had lower rates of early overall recurrence (131 [24.6%] vs 196 [36.8%]; P < .001) and early distant metastasis (73 [13.7%] vs 125 [23.5%]; P < .001) than the NCRT group. Multivariable regression analysis identified NCRT (vs NCIT), higher ypN stage, and not achieving a major pathological response as independent risk factors for both early overall recurrence and early distant metastasis. Among patients who experienced early recurrence, post-recurrence survival did not differ between the 2 modalities (HR, 0.81; 95% CI, 0.63-1.04; P = .086). Although the NCRT group had a higher major pathological response rate, NCIT was associated with better early recurrence control even among patients achieving a major pathological response (HR, 0.61; 95% CI, 0.47-0.84; P < .001).
Conclusions
Compared with NCRT, NCIT is associated with a lower incidence of early recurrence, particularly distant metastasis, which may contribute to the observed OS advantage. The poor prognosis after early recurrence highlights the need for intensified post-operative surveillance in high-risk patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Taizhou Hospital of Zhejiang Province affiliated with Wenzhou Medical University, Linhai 317000, China.
- Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
- Department of Cardiothoracic Surgery, The Second Affiliated Hospital, Jiaxing University, Jiaxing 314000, China.
- Taizhou Hospital, Zhejiang University School of Medicine, Taizhou 318000, China.
- Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
- Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong 999077, China.
ORCID-Profile: Cien Sun, Chunji Chen, Zhigang Li, Zhichao Liu, Jianfei Shen
Förderung
- Medical and Health Science and Technology Project of Zhejiang Province
- Scientific Research Foundation of Taizhou Enze Medical Center
Zitieren
APA
Sun, C., Chen, C., Sun, H., Liu, H., Chen, Q., Wang, Z., Chen, J., Cho, W. C., Li, Z., Liu, Z., Ma, D., Ye, M., Wang, C., Wang, Q., Leng, X., Han, Y., Wang, Q., Lv, J., Chen, H., …, & Shen, J. (2026). Early Recurrence Patterns After Neoadjuvant Chemoradiotherapy and Chemoimmunotherapy in Oesophageal Squamous Cell Carcinoma: A Multicentre Study. European Journal of Cardio-Thoracic Surgery, 68(11-12). https://doi.org/10.1093/ejcts/ezag219
Vancouver
Sun C, Chen C, Sun H, Liu H, Chen Q, Wang Z, et al. Early Recurrence Patterns After Neoadjuvant Chemoradiotherapy and Chemoimmunotherapy in Oesophageal Squamous Cell Carcinoma: A Multicentre Study. European Journal of Cardio-Thoracic Surgery. 2026;68(11-12). doi:10.1093/ejcts/ezag219
BibTeX
@article{Sun2026,
author = {Sun, Cien and Chen, Chunji and Sun, Hua and Liu, Hao and Chen, Qianyi and Wang, Zimin and Chen, Jiawen and Cho, William C and Li, Zhigang and Liu, Zhichao and Ma, Dehua and Ye, Minhua and Wang, Chunguo and Wang, QinYa and Leng, Xuefeng and Han, Yongtao and Wang, Qifeng and Lv, Jiahua and Chen, Hainan and Zhao, Jinbo and Yan, Xiaolong and Lv, Huilai and Tian, Ziqiang and Wang, Changchun and Xu, Liwei and Jiang, Youhua and Zhang, Zhengyang and Zhong, Qihong and Lin, Jiangbo and Mei, Xinyu and Li, Xiaoyang and Qian, Dong and Zhu, Chengchu and Guo, Xufeng and Shen, Jianfei},
title = {Early Recurrence Patterns After Neoadjuvant Chemoradiotherapy and Chemoimmunotherapy in Oesophageal Squamous Cell Carcinoma: A Multicentre Study},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2026},
volume = {68},
number = {11-12},
doi = {10.1093/ejcts/ezag219}
}
EUVIMED